XML 59 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
Selected Quarterly Financial Data (Unaudited)
12 Months Ended
Dec. 31, 2013
Selected Quarterly Financial Data (Unaudited) [Abstract]  
Selected Quarterly Financial Data (Unaudited)
Note 17 –   Selected Quarterly Financial Data (Unaudited)

The following table contains unaudited statement of operations information for each quarter of 2013 and 2012.  The operating results for any quarter are not necessarily indicative of results for any future period.

2013 Quarters Ended:
      
(in thousands, except per share data)
 
Mar. 31
  
June 30
  
Sept. 30
  
Dec. 31
  
Total Year
 
Grant revenues
 
$
72
  
$
182
  
$
60
  
$
74
  
$
388
 
Expenses:
                    
Cost of sales
  
   
   
   
517
   
517
 
Research and development
  
8,472
   
6,863
   
6,574
   
5,752
   
27,661
 
Selling, General and administrative
  
4,220
   
4,129
   
4,299
   
4,070
   
16,718
 
Total expenses
  
12,692
   
10,992
   
10,873
   
10,339
   
44,896
 
Operating loss
  
(12,620
)
  
(10,810
)
  
(10,813
)
  
(10,265
)
  
(44,508
)
Change in fair value of common stock warrant liability
  
162
   
2,525
   
(1,059
)
  
(867
)
  
761
 
Other expense, net
  
(177
)
  
(342
)
  
(352
)
  
(597
)
  
(1,468
)
Net loss
 
$
(12,635
)
 
$
(8,627
)
 
$
(12,224
)
 
$
(11,729
)
 
$
(45,215
)
Net loss per common share - basic
 
$
(0.29
)
 
$
(0.18
)
 
$
(0.22
)
 
$
(0.16
)
 
$
(0.82
)
Net loss per common share - diluted
  
(0.29
)
  
(0.22
)
  
(0.22
)
  
(0.16
)
  
(0.82
)
Weighted average number of common shares outstanding - basic
  
43,657
   
49,135
   
54,792
   
73,129
   
55,258
 
Weighted average number of common shares outstanding - diluted
  
43,657
   
49,866
   
54,792
   
73,129
   
55,258
 
 
2012 Quarters Ended:
 
 
(in thousands, except per share data)
 
Mar. 31
  
June 30
  
Sept. 30
  
Dec. 31
  
Total Year
 
Grant Revenues
 
$
  
$
  
$
  
$
195
  
$
195
 
Expenses:
                    
Research and development
  
4,533
   
5,206
   
5,743
   
6,088
   
21,570
 
General and administrative
  
2,047
   
3,610
   
4,255
   
6,532
   
16,444
 
Total expenses
  
6,580
   
8,816
   
9,998
   
12,620
   
38,014
 
Operating loss
  
(6,580
)
  
(8,816
)
  
(9,998
)
  
(12,425
)
  
(37,819
)
Change in fair value of common stock warrant liability
  
(3,434
)
  
1,680
   
(3,309
)
  
5,618
   
555
 
Other expense, net
  
(2
)
  
(2
)
  
(39
)
  
(8
)
  
(51
)
Net loss
 
$
(10,016
)
 
$
(7,138
)
 
$
(13,346
)
 
$
(6,815
)
 
$
( 37,315
)
Net loss per common share -  basic and diluted
 
$
(0.37
)
 
$
(0.16
)
 
$
(0.31
)
 
$
(0.16
)
 
$
(0.95
)
Weighted average number of common shares outstanding
  
27,162
   
43,369
   
43,444
   
43,521
   
39,396